These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31155185)

  • 1. Risk Factors for Refractory Ascites After Living Donor Liver Transplant.
    Sato K; Ohira M; Shimizu S; Imaoka Y; Hashimoto S; Tahara H; Kobayashi T; Kuroda S; Ide K; Tanaka Y; Ohdan H
    Transplant Proc; 2019 Jun; 51(5):1516-1519. PubMed ID: 31155185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipient's body weight.
    Shirouzu Y; Ohya Y; Suda H; Asonuma K; Inomata Y
    Clin Transplant; 2010; 24(4):520-7. PubMed ID: 19843111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent risk factors for massive ascites after living donor liver transplantation in adults.
    Li C; Lu Q; Luo J; Zhang Z
    Transplant Proc; 2014 Apr; 46(3):883-7. PubMed ID: 24767372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.
    Chok KSh; Chan SC; Fung JY; Cheung TT; Chan AC; Fan ST; Lo CM
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):256-62. PubMed ID: 23742770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Graft Quality and Fluid Overload on Postoperative Massive Ascites After Living Donor Liver Transplantation.
    Iwaki K; Yagi S; Morita S; Hamaguchi Y; Masano Y; Yamamoto G; Ogawa E; Nagai K; Kamo N; Hata K; Taura K; Okajima H; Kaido T; Uemoto S
    Transplant Proc; 2019; 51(6):1779-1784. PubMed ID: 31301855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transjugular intrahepatic portosystemic shunts in liver transplant recipients for management of refractory ascites: clinical outcome.
    Saad WE; Darwish WM; Davies MG; Waldman DL
    J Vasc Interv Radiol; 2010 Feb; 21(2):218-23. PubMed ID: 20123207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behavior and clinical impact of ascites after living donor liver transplantation: risk factors associated with massive ascites.
    Ito D; Akamatsu N; Togashi J; Kaneko J; Arita J; Hasegawa K; Sakamoto Y; Kokudo N
    J Hepatobiliary Pancreat Sci; 2016 Nov; 23(11):688-696. PubMed ID: 27474897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-Transplantation Immune Cell Distribution and Early Post-Transplant Fungal Infection Are the Main Risk Factors of Liver Transplantation Recipients in Lower Model of End-Stage Liver Disease.
    Abdelhamid NM; Chen YC; Wang YC; Cheng CH; Wu TJ; Lee CF; Wu TH; Chou HS; Chan KM; Lee WC; Soong RS
    Transplant Proc; 2017; 49(1):92-97. PubMed ID: 28104167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification for early bacteremia after living donor liver transplantation: a retrospective observational cohort study.
    Park J; Kim BW; Choi HJ; Hong SH; Park CS; Choi JH; Chae MS
    BMC Surg; 2020 Mar; 20(1):2. PubMed ID: 32160890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for massive ascites after living donor liver transplantation in adult and impact of massive ascites on patient survival].
    Li CT; Luo J; Zhang ZW; He H; He WJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Jul; 44(4):632-6. PubMed ID: 24059124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
    Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
    Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation.
    Alim A; Erdogan Y; Yuzer Y; Tokat Y; Oezcelik A
    Liver Transpl; 2016 Dec; 22(12):1643-1648. PubMed ID: 27509534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation.
    Reddy MS; Kaliamoorthy I; Rajakumar A; Malleeshwaran S; Appuswamy E; Lakshmi S; Varghese J; Rela M
    Liver Transpl; 2017 Aug; 23(8):1007-1014. PubMed ID: 28294557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of Proper Graft Selection in Adult Living-Donor Liver Transplant Recipients with Preoperative Deteriorated Condition.
    Iida T; Masuda K; Matsuyama T; Harada S; Nakamura T; Koshino K; Suzuki T; Nobori S; Ushogome H; Ito T; Sakamoto S; Uryuhara K; Okajima H; Kaihara S; Uemoto S; Yoshimura N
    Ann Transplant; 2017 Sep; 22():541-549. PubMed ID: 28883387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (D+10) MELD as a novel predictor of patient and graft survival after adult to adult living donor liver transplantation.
    Soin AS; Goja S; Yadav SK; Tamang TY; Rastogi A; Bhangui P; Thiagrajan S; Raut V; Babu RY; Saigal S; Saraf N; Choudhary NS; Vohara V
    Clin Transplant; 2017 May; 31(5):. PubMed ID: 28239914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.